Citigroup’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,000
| Closed | -$639K | – | 5676 |
|
|
2024
Q4 | $639K | Hold |
50,000
| – | – | ﹤0.01% | 3659 |
|
|
2024
Q3 | $557K | Buy |
+50,000
| New | +$551K | ﹤0.01% | 3660 |
|
|
2021
Q1 | – | Sell |
-22,900
| Closed | -$102K | – | 6520 |
|
|
2020
Q4 | $102K | Buy |
22,900
+3,200
| +16% | +$14.5K | ﹤0.01% | 5515 |
|
|
2020
Q3 | $85K | Sell |
19,700
-10,200
| -34% | -$72.8K | ﹤0.01% | 5234 |
|
|
2020
Q2 | $265K | Buy |
29,900
+9,600
| +47% | +$48.5K | ﹤0.01% | 4801 |
|
|
2020
Q1 | $72K | Sell |
20,300
-55,200
| -73% | -$256K | ﹤0.01% | 5642 |
|
|
2019
Q4 | $432K | Sell |
75,500
-29,800
| -28% | -$159K | ﹤0.01% | 4546 |
|
|
2019
Q3 | $376K | Buy |
105,300
+85,400
| +429% | +$331K | ﹤0.01% | 4609 |
|
|
2019
Q2 | $79K | Sell |
19,900
-7,300
| -27% | -$42.3K | ﹤0.01% | 6078 |
|
|
2019
Q1 | $199K | Sell |
27,200
-35,000
| -56% | -$342K | ﹤0.01% | 5104 |
|
|
2018
Q4 | $569K | Buy |
62,200
+30,700
| +97% | +$340K | ﹤0.01% | 3988 |
|
|
2018
Q3 | $391K | Buy |
31,500
+17,000
| +117% | +$230K | ﹤0.01% | 4567 |
|
|
2018
Q2 | $221K | Sell |
14,500
-11,100
| -43% | -$192K | ﹤0.01% | 4961 |
|
|
2018
Q1 | $508K | Buy |
25,600
+8,600
| +51% | +$149K | ﹤0.01% | 3980 |
|
|
2017
Q4 | $318K | Sell |
17,000
-15,900
| -48% | -$319K | ﹤0.01% | 4583 |
|
|
2017
Q3 | $707K | Sell |
32,900
-17,600
| -35% | -$278K | ﹤0.01% | 3736 |
|
|
2017
Q2 | $487K | Buy |
50,500
+41,700
| +474% | +$271K | ﹤0.01% | 4018 |
|
|
2017
Q1 | $52K | Buy |
8,800
+1,500
| +21% | +$7.21K | ﹤0.01% | 5663 |
|
|
2016
Q4 | $29K | Buy |
+7,300
| New | +$53.5K | ﹤0.01% | 6380 |
|
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$1.23M | – | 7617 |
|
|
2015
Q3 | $1.23M | Hold |
50,000
| – | – | ﹤0.01% | 2889 |
|
|
2015
Q2 | $1.17M | Buy |
+50,000
| New | +$1.09M | ﹤0.01% | 3027 |
|
Other funds holding DVAX
Citigroup's DVAX Position: Q1 2026 in Review
Citigroup sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 47,601 shares — an estimated $732K sold.
Citigroup first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $15.3M in Q3 2017. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Citigroup reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 47,601 Dynavax Technologies shares in Q1 2026, an estimated $732K.
- Citigroup first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
- Citigroup's Dynavax Technologies position peaked at $15.3M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.